XENO
Live / Registered — Registered and renewed (as of 19 Sept 2022)
What this means for you
Registered since 27 Mar 2012. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 27 Mar 2022).
Record
- Serial number
- 85394838
- Registration number
- 4118527
- Mark type
- Design + words
- Filed
- 10 Aug 2011
- Published for opposition
- 10 Jan 2012
- Registered
- 27 Mar 2012
- Next maintenance due
- 27 Mar 2022
- Attorney of record
- Dana S. Gross
Goods and services
- Class 001 — Chemicals: Recombinant proteins used as reagents for drug discovery and research
Owner
- HumanZyme Inc., Chicago, IL, US
- HumanZyme Inc., Chicago, IL, US
- HumanZyme Inc., Chicago, IL, US
Prosecution history
- 19 Sept 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 19 Sept 2022 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 19 Sept 2022 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 19 Sept 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 24 Mar 2022 — TEAS SECTION 8 & 9 RECEIVED
- 27 Mar 2021 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 08 Oct 2018 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 08 Oct 2018 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 07 Oct 2018 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 03 Oct 2018 — POST REGISTRATION ACTION MAILED - SEC. 8 & 15
- 01 Oct 2018 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 06 Apr 2018 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 06 Apr 2018 — POST REGISTRATION ACTION MAILED - SEC. 8 & 15
- 06 Apr 2018 — POST REGISTRATION ACTION CORRECTION
- 06 Apr 2018 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL